MedPath

Sleep Hygiene Education in Individuals With Fibromyalgia; Sleep Quality, Pain and Depression

Not Applicable
Completed
Conditions
Fibromyalgia
Registration Number
NCT06276855
Lead Sponsor
Cumhuriyet University
Brief Summary

Objective: This semi-experimental study was conducted to determine the effect of sleep hygiene education on sleep quality, pain, and depression in individuals with fibromyalgia.

Patients and methods: A sample of 70 individuals with fibromyalgia (35 experimental, 35 control) were included in the study. Data was collected using the Pittsburgh Sleep Quality Index, the Visual Analog Scale, and the Beck Depression Inventory.

Detailed Description

Objective: This semi-experimental study was conducted to determine the effect of sleep hygiene education on sleep quality, pain, and depression in individuals with fibromyalgia.

Background: Sleep problems, pain, and depression are common health issues in individuals with fibromyalgia. However, studies on sleep hygiene education to address these problems are limited in the literature.

Methods: A sample of 70 individuals with fibromyalgia (35 experimental, 35 control) were included in the study. Data was collected using the Pittsburgh Sleep Quality Index, the Visual Analog Scale, and the Beck Depression Inventory.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria

The inclusion criteria for the study were as follows:

  • Being 18 years of age or older,
  • Having a diagnosis of Fibromyalgia (FM) for at least 3 months,
  • Being reachable,
  • Agreeing to participate in the study,
  • Not receiving treatment for depression,
  • Not having received similar education on sleep hygiene,
  • Having a VAS pain score >3,
  • Having a PSQI score >5.
Exclusion Criteria

Additionally, the exclusion criteria for the study were as follows:

  • Having a diagnosis of FM for less than 3 months,
  • Using sleep medication,
  • Having chronic illnesses that could interfere with sleep such as Chronic Obstructive Pulmonary Disease (COPD) or asthma,
  • Working on night shifts.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale (VAS).1 month

The VAS is a valid and reliable scale to measure the intensity of chronic pain. It is rated from "0 = no pain" to "10 = worst possible pain". The intervals for pain intensity are \<3 for mild pain, 3-6 for moderate pain, and \>6 for severe pain. The Cronbach's alpha value of the scale is 0.97. In this study, the Cronbach's alpha was found to be 0.92.

Pittsburgh Sleep Quality Index (PSQI).1 month

The PSQI evaluates the quality of sleep in the last month. It consists of 19 items and 7 components. Each item is evaluated on a 0-3 point scale, and the sum of scores from seven components gives the total PSQI score. The total score ranges from 0 to 21. A high total score indicates poor sleep quality. A total PSQI score of ≤5 indicates "good sleep," while a score of \>5 indicates "poor sleep." The Cronbach's alpha value of the scale is 0.80. In this study, the Cronbach's alpha was found to be 0.83.

Beck Depression Inventory (BDI).1 month

The scale consists of a total of 21 items. The highest possible total score is 63. A high total score indicates a higher level of depression. The severity of depression is categorized as follows: 0-9 = minimal, 10-16 = mild, 17-29 = moderate, and 30-63 = severe depression. The internal consistency coefficient of the scale is 0.86. In this study, the Cronbach's alpha was found to be 0.83.

Demographic Information Form (DIF).1 month

This form was prepared by the researcher based on the literature and consists of 10 questions about the FM patients' sociodemographic and disease characteristics (age, gender, educational status, etc.).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sivas Cumhuriyet University

🇹🇷

Sivas, Center, Turkey

Sivas Cumhuriyet University
🇹🇷Sivas, Center, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.